Alimta

... Eli Lilly Profit Jumps QUOTES & SEARCH Quotes Search Site Advanced Search MY STOCKWATCH Select your StockWatch HOT NEWS Analyst ActionsLatest Stories NEWS AND ANALYSIS Tech StocksMarkets ETFs Small Business CommentaryPersonal FinanceThe Good LifeCompany NewsOptions and Futures FEATURED OFFERS Free MembershipAction Alerts PLUSStocks Under $10The Short AdvisorDividend Stock AdvisorThe Trading ReportsCramer RadioCramer's BooksTheStreet.com Value InvestorTelecom ConnectionDaily Swing TradeThe Tech EdgeChartman's Top StocksRealMoney Free TrialBrokersInstitutions CUSTOMER SERVICE Account InfoPasswordLogoutRSS ABOUT US LettersInvestor RelationsCorrections RESEARCH/TOOLS Earnings ReportsMutual Fund FinderStreaming QuotesEconomic CalendarInternet Index Stock News : Biotech/Pharmaceuticals Eli Lilly Profit Jumps By TSC Staff 1/26/2005 8:15 AM EST Eli Lilly (LLY :NYSE - news - research) Wednesday posted solidly higher fourth-quarter net income, edging past analysts' EPS estimates thanks to its latest generation of drugs.

The Indianapolis-based drugmaker had a net loss of $2.4 million, equivalent to zero cents a share, primarily due to a $465.0 million tax expense on the expected repatriation to the U.S.

of $8.0 billion of eligible overseas earnings in 2005 under the American Jobs Creation Act of 2004, as well as the charges for the previously announced restructuring initiatives.

That compares with a profit of $747.2 million, or 69 cents a share, in the year-ago period.

Lilly ...

Read more...